NCT07261618

Brief Summary

Timely detection of fetal brain anomalies is critical for improving prenatal counseling and postnatal neurological outcomes. Ultrasonography is the most commonly used and effective imaging method for evaluating fetal structures; however, diagnostic accuracy can be affected by operator experience, fetal position, and image quality, leading to variability in interpretation. Artificial intelligence (AI)-based image analysis offers a new opportunity to standardize diagnostic assessment and reduce subjectivity in ultrasound interpretation. This study aims to evaluate the diagnostic accuracy and clinical applicability of an AI-assisted model (Alyssia) designed to analyze archived 2D fetal brain ultrasound images. The model will be trained and validated to distinguish between normal and abnormal intracranial findings, focusing particularly on the lateral ventricles and other relevant brain regions. The research employs an observational, retrospective design using anonymized ultrasound data obtained during routine prenatal examinations between 18 and 24 weeks of gestation. Expert clinicians will review and label all eligible images to establish ground truth classifications for model training and validation. A deep learning-based algorithm will be developed to automatically classify these images, and its performance will be evaluated using accuracy, sensitivity, specificity, precision, and F1-score metrics. Misclassified cases will be qualitatively analyzed to determine contributing factors such as image quality, anatomical variability, and gestational differences. By comparing AI model outputs with expert-labeled references, the study will assess the model's ability to enhance diagnostic standardization and reduce inter-observer variability. The findings are expected to provide valuable insights into the integration of AI-based decision support systems in prenatal neurosonography. Ultimately, this research aims to support earlier and more reliable detection of fetal brain anomalies, contributing to improved prenatal care and healthier outcomes for mothers and infants.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 21, 2025

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 3, 2025

Completed
Last Updated

December 3, 2025

Status Verified

November 1, 2025

Enrollment Period

2 months

First QC Date

November 21, 2025

Last Update Submit

November 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic Accuracy of the AI-Assisted Model (Alyssia)

    The primary outcome is the diagnostic accuracy of the Alyssia artificial intelligence model in classifying archived 2D fetal brain ultrasound images as normal or abnormal. Model performance will be evaluated by comparing AI-generated classifications with expert-labeled ground truth data.

    From study start to model validation (approximately 6 weeks).

Study Arms (2)

Normal Fetal Brain Images

Archived 2D fetal brain ultrasound images classified as normal by expert reviewers.

Diagnostic Test: Alyssia - AI-Assisted Diagnostic Model for Fetal Brain Ultrasound

Abnormal Fetal Brain Images

Archived 2D fetal brain ultrasound images with confirmed intracranial anomalies, labeled by experts.

Diagnostic Test: Alyssia - AI-Assisted Diagnostic Model for Fetal Brain Ultrasound

Interventions

Artificial intelligence-based diagnostic tool designed to classify archived 2D fetal brain ultrasound images as normal or abnormal to detect intracranial anomalies.

Abnormal Fetal Brain ImagesNormal Fetal Brain Images

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This study will use archived and anonymized 2D fetal brain ultrasound images obtained during routine prenatal screening examinations conducted between the 18th and 24th weeks of gestation. The dataset represents a diverse population of pregnant individuals aged 18-45 years who underwent standard obstetric ultrasound evaluations. All images were acquired as part of routine clinical care and stored in the institutional digital archive. Only diagnostically adequate images clearly displaying the lateral ventricles and other intracranial regions were included. The study population therefore consists of ultrasound records rather than direct human participants, ensuring complete anonymity and protection of personal data.

You may qualify if:

  • Archived 2D fetal brain ultrasound images obtained during routine prenatal examinations.
  • Gestational age between 18 and 24 weeks at the time of imaging.
  • Maternal age between 18 and 45 years.
  • Clear visualization of the lateral ventricles and other intracranial regions.
  • Images meeting diagnostic quality standards suitable for analysis.
  • Fully anonymized images with no patient identifiers.
  • Availability of expert assessment to classify each image as normal or abnormal.

You may not qualify if:

  • Ultrasound images with poor diagnostic quality or motion artifacts.
  • Incomplete, duplicate, or corrupted image records.
  • Ambiguous gestational age or missing clinical metadata.
  • Images containing any identifiable patient information.
  • Cases outside the specified gestational window (before 18 or after 24 weeks).
  • Images unrelated to the fetal brain (misfiled or mislabeled data).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nefise nazlı Yenigül

Bursa, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Obstetrics and Gynecology

Study Record Dates

First Submitted

November 21, 2025

First Posted

December 3, 2025

Study Start

October 15, 2025

Primary Completion

November 30, 2025

Study Completion

November 30, 2025

Last Updated

December 3, 2025

Record last verified: 2025-11

Locations